Regulatory Judgment Built From Doing The Work

FDA RA Group is a senior regulatory and quality consulting firm for medical device and IVD companies navigating consequential FDA decisions. Our work is grounded in direct experience developing submissions, leading quality and compliance programs, preparing for FDA oversight, and managing complex postmarket obligations.

Real experience. Practical solutions. Better outcomes.
Experience In Practice

Experience matters most when the answer is not obvious

Our team has worked inside the decisions that connect regulatory strategy, evidence, quality systems, manufacturing, FDA interactions, and postmarket obligations. That breadth helps us understand what one decision can mean for everything that follows.

We understand both sides of the FDA conversation

Our experience includes former FDA lead review and senior industry roles responsible for submissions, inspections, and compliance decisions.

We connect the regulatory answer to the business reality

Recommendations consider the operational, timing, evidence, and implementation consequences that follow.

We stay with the work after the decision is made

From authoring and FDA response through implementation and postmarket change, we remain close to execution.

A senior team built on trusted experience

Different perspectives. A stronger path forward.

FDA RA Group brings together highly experienced regulatory and quality professionals who have worked extensively in industry and at FDA, including former FDA lead reviewer experience. Our consultants bring decades of combined experience across medical devices, IVDs, clinical diagnostics, quality systems, inspections, submissions, remediation, and postmarket regulatory work.

Engagements are matched to the expertise the work requires, with senior professionals remaining directly involved from strategy through execution. The goal is simple: experienced judgment, practical support, and work that holds up when the stakes are high.

Senior regulatory and quality professionals collaborating on a complex regulatory strategy
Experience Across the FDA Lifecycle

Experience from early strategy through postmarket

Strategy
Clinical
510(k)
De Novo
PMA
PMA Supplements
QMSR / ISO 13485
FDA Inspections
Remediation
Postmarket

From clinical strategy and premarket submissions to manufacturing changes, inspections, remediation, and postmarket obligations, our team understands the regulatory, quality, and operational decisions that affect timelines, resources, and business objectives.

The people advising your business have actually done the work

Our consultants bring firsthand experience writing submissions, managing FDA interactions, building quality systems, preparing for inspections, leading remediation, evaluating manufacturing and software changes, supporting labeling, and managing postmarket obligations.

We understand what it takes to move a product forward and stay engaged until the work is done.

Medical device regulatory and quality consulting
Medical Device Journey

The Stakes Are High

Bringing a medical device to market requires more than technical expertise. Without rigorous quality assurance and clear regulatory strategy, even the most promising innovations can stall or fail. Every step of the journey demands precision, compliance, and foresight.

Strategy Defines the Path

Choosing the right regulatory pathway

Framing the regulatory position

Identifying evidence requirements

Anticipating FDA questions and risk

Aligning regulatory decisions with business objectives

Execution Carries It Through

Building and authoring the submission

Defending the regulatory rationale

Managing FDA questions and responses

Implementing approved changes

Maintaining compliance through postmarket

A Trusted Partner Across the Full Journey

Our Commitment

Your goalsare our priority

Objective, experience based advice

Direct access to senior consultants

Hands on support from strategy through execution

Practical, achievable solutions

Confidential and trustworthy partnerships

Professional judgment focused on your business objectives

Let's Talk

Bring Us Your Most Complex Regulatory Question

Contact Us